• 대한방사선방어학회:학술대회논문집
• /
• 2009.11a
• /
• pp.52-54
• /
• 2009

• 대한방사선방어학회:학술대회논문집
• /
• 2009.04a
• /
• pp.264-265
• /
• 2009

• Radiation Oncology Journal
• /
• v.13 no.4
• /
• pp.331-338
• /
• 1995

Purpose : To evaluate our clinical experience with the combination of teletherapy and intraluminal brachytherapy in patients with unresectable or inoperable esophageal cancers. Materials and Methods : From Nov 1989 to Mar 1993, twenty patients with esophageal cancer were treated with radical radiotherapy and intraluminal brachytherapy at Yonsei Cancer Center. All patients had squamous histolgy and stage distribution was as follows: stage II, 4($20{\%}$)patients; III, 15 ($75{\%}$)patients; IV, 1($5{\%}$)patients. A dose of S-12Gy/1-3weeks with intraluminal brachytherapy (3-5Gy/fraction) to 5mm from the outside of the esophageal tube using high dose rate Iridium-192 remotely afterloading brachytherapy machine was given 2 weeks after a total dose of 59-64Gy with external radiotherapy. Induction chemotherapy using cisplatin and 5-FU was performed in 13 patients with median 3 cycles(1-6 cycles), Response rate, local control rate, survival and complications were analysed retrospectively. Results : Two-year overall survival rate and median survival were $15.8{\%}$ and 13.5 months. Response rates were as follows complete remission(CR) 5($25{\%}$): partial remission a(PRa) 7($35{\%}$): partial remission b(PRb) 7($35{\%}$), no response(NR) 1($5{\%}$). Patterns of failure were as follows; local failure 13($65{\%}$), local and distant failure 3($15{\%}$), distant failure 0($0{\%}$). Ultimate local control rate was $20{\%}$. Treatment related complications included esophageal ulcer in two patients and esophageal stricture in one. Conclusion : Though poor local conrol rate, median survival was improved as compared with previous results of radiation therapy alone(8months) and chemoradiation combined treatment(11 months) in Yonsei Cancer Center High-dose-rate intraluminal brachytherapy following external irradiation is an effective treatment modality with acceptable toxicity in esophageal cancer.

• Progress in Medical Physics
• /
• v.24 no.3
• /
• pp.171-175
• /
• 2013

Applicator of various kind of number ten kinds is used to raise from efficiency of brachytherapy to maximum. The compatibility of radiation source and applicator is very important subject for safety brachytherapy. Developed high dose rate brachytherapy source through Hanaro nuclear reactor in Korea Atomic Energy Research Institute and improve compatibility with using equipment in present. In this research, we wished to evaluate stability mechanical safety of radiation source and we developed phantom for evaluate several quality about Ir-192 sealed source that improve newly in Korea Atomic Energy Research Institute and is improved. The result for suitability of Ir-192 HDR source with brachytherapy tools that did normal operation in 2.2~2.7 cm extent about change of equal curvature and consider change of sudden curvature that did normal operation in radius 1.5~1.8 cm extent.

• Journal of the Korean Society of Radiology
• /
• v.14 no.5
• /
• pp.523-528
• /
• 2020

The application of breast cancer, which has the highest incidence in females among cancer that is the number one cause of death for dogs, was to be evaluated the absorbed dose during brachytherapy using simulation. MCNPX program was used for simulation, and a small size canine phantom was produced to measure absorbed dose. The results of the absorbed dose was the highest at ¹⁹²Ir to 1.02E-12 Gy/# for tumors, and the same tendency was shown for internal and external absorbed dose. Therefore, the selection of appropriate sources for dog breast cancer should be considered in brachytherapy, taking into account dog breeds and exposures.

• Journal of the Korean Society of Radiology
• /
• v.10 no.4
• /
• pp.271-278
• /
• 2016

This study was fulfilled to evaluate the absorbed dose of breast and adjacent organs using MIRD type phantom in brachytherapy of breast cancer. The absorbed dose was analyzed assuming left or right breast is source organ which is $^{103}Pd$ or $^{192}Ir$. As a result, $^{192}Ir$ dose is higher than $^{103}Pd$ in source organ and also in contralateral breast. Particularly, significant adjacent organs are lung, liver, heart and contralateral breast in brachytherapy of breast cancer.

• Journal of Yeungnam Medical Science
• /
• v.17 no.2
• /
• pp.123-128
• /
• 2000

Purpose: This study was aimed to develop a new vaginal applicator(Shin's Applicator) for 2-channel high-dose rate vaginal brachytherapy to evaluate uniformity of surface dose, and to present 3-dimensional dose distribution of the applicator. Methods: Shin's Applicator was inexpensively constructed using human soft tissue equivalent acrylic bar. We evaluated dose uniformity along the applicator surface using film densitometer and performed vaginal intracavitary brachytherapy after insertion of the applicator using HDR brachytherapy planning software and brachytherapy unit(Ralstron-20B). Results: Shin's Applicator allows improved dose distribution than the existing 1-channel cylinder and achieves diminished urinary bladder and rectal dose by 20%. Conclusions: From the above results, it can be concluded that Shin's Applicator may be an improved form of a vaginal applicator. Furthermore, it can be suggested that this applicator has an advantage, for it prevents vaginal stenosis after radiation therapy and can be used as a disposable vaginal dilator. Further follow up examination with radiological study may be helpful to evaluate the therapeutic efficacy of this applicator.

• The Journal of Korean Society for Radiation Therapy
• /
• v.8 no.1
• /
• pp.119-122
• /
• 1996

• 대한방사선치료학회:학술대회논문집
• /
• 1998.06a
• /
• pp.14-15
• /
• 1998

• 대한방사선치료학회:학술대회논문집
• /
• 2001.06a
• /
• pp.8-9
• /
• 2001